As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CVS Health: Hudson Bay Capital Management LP, Nomura Holdings Inc., Man Group plc, Hudson Bay Capital Management LP, Group One Trading LLC, BNP Paribas Financial Markets, Balyasny Asset Management L.P., Bank of America Corp DE, Jane Street Group LLC, Squarepoint Ops LLC, Dymon Asia Capital Singapore PTE. LTD., Stempoint Capital LP, Qube Research & Technologies Ltd, Maven Securities LTD, Capula Management Ltd, Walleye Capital LLC, Walleye Trading LLC, Mackenzie Financial Corp, Capital Fund Management S.A., Eisler Capital Management Ltd., JPMorgan Chase & Co., Citigroup Inc., Bank of Montreal Can, Wolverine Asset Management LLC, Arkadios Wealth Advisors, FNY Investment Advisers LLC, Allianz Asset Management GmbH, Twin Tree Management LP, and Vontobel Holding Ltd.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.